| Age group
(years) | No. of definite/(probable and definite) prostate cancer deaths | Person-years | Mortality
Definite prostate cancer death (95% CI) | Mortality
Definite and probable prostate cancer deaths (95% CI) |
| | 0–4 | 0 | 140,154 | — | — | | 5–9 | 0 | 150,870 | — | — | | 10–14 | 0 | 150,615 | — | — | | 15–19 | 0 | 152,055 | — | — | | 20–24 | 0 | 144,420 | — | — | | 25–29 | 0 | 158,970 | — | — | | 30–34 | 1 | 155,280 | 0.6 (0–3.6) | 0.6 (0–3.6) | | 35–39 | 0 | 164,910 | — | — | | 40–44 | 0/0 | 154,320 | — | — | | 45–49 | 7/7 | 128,985 | 5.4 (2.2–11.2) | 5.4 (2.2–11.2) | | 50–54 | 25/26 | 105,450 | 23.7 (15.3–35.0) | 24.7 (16.1–36.1) | | 55–59 | 25/28 | 70,350 | 35.5 (23.0–52.5) | 39.8 (26.4–57.5) | | 60–64 | 61/71 | 64,035 | 95.3 (72.9–122.4) | 110.9 (86.6–139.9) | | 65–69 | 80/104 | 58,845 | 136.0 (107.8–169.2) | 176.7 (144.4–214.1) | | 70–74 | 132/166 | 52,095 | 253.4 (212.0–300.5) | 318.6 (272.0–371.0) | | 75–79 | 173/230 | 37,770 | 458.0 (392.3–531.6) | 608.9 (532.8–692.9) | | 80–84 | 212/276 | 27,375 | 774.4 (673.7–866.0) | 1,008.2 (892.8–1,134.5) | | 85+ | 225/326 | 21,165 | 1,063.1 (928.7–1,211.4) | 1,540.3 (1,377.6–1,716.9) | | Age unknown | 2/2 | — | — | | | Total | 943/1,237 | 1,937,664 | | | | Crude rate | | | 48.6 (45.5–51.8) | 63.7 (60.2–67.3) | | Age-standardized rates (US) | — | — | 62.7 (58.8–66.9) | 82.7 (78.1–87.4) | | Age-standardized rates (Europe) | — | — | 49.6 (46.4–53.0) | 64.3 (60.7–68.2) | | Age-standardized rates (World) | — | — | 29.7 (27.7–31.9) | 38.1 (35.8–40.6) |
|
|
